Close

Cellectis (CLLS) Says Two Issued U.S. Patents Granted for CRISPR Use in T-Cells

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/1/2023

1. SPY
2. NKE
3. TSLA
4. AAPL
5. F
6. STLA
7. GM
8. GOOGL
9. FOLD
10. CCL


Go back to Cellectis (CLLS) Says Two Issued U.S. Patents Granted for CRISPR Use in T-Cells
(NASDAQ: CLLS) Delayed: 1.58 --0 (-0%)
Previous Close $1.58    52 Week High $37.55 
Open $1.58    52 Week Low $16.35 
Day High $1.59    P/E N/A 
Day Low $1.58    EPS $0.00 
Volume 7,365